2 weeks Ago By Defense World Staff
Norges Bank acquired a new position in shares of Tempus AI, Inc. ( NASDAQ:TEM – Free Report ) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,027,284 shares of the company’s stock, valued at approximately $34,681,000.
Norges Bank owned 0.65% of Tempus AI at the end of the most recent reporting period. Several other large investors have also recently bought and sold shares of the business.
Farther Finance Advisors LLC purchased a new position in Tempus AI in the fourth quarter valued at about $34,000. Prestige Wealth Management Group LLC boosted its stake in shares of Tempus AI by 910.4% during the 4th quarter.
Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after acquiring an additional 965 shares in the last quarter. First Horizon Advisors Inc. grew its holdings in shares of Tempus AI by 207.
9% in the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock worth $55,000 after acquiring an additional 1,108 shares during the period.
FNY Investment Advisers LLC purchased a new position in Tempus AI in the 4th quarter valued at approximately $67,000. Finally, IFP Advisors Inc acquired a new position in Tempus AI during the fourth quarter worth $76,000. Hedge funds and other institutional investors own 24.
22% of the company’s stock. Analyst Upgrades and Downgrades Several analysts have weighed in on TEM shares. Loop Capital lowered their target price on Tempus AI from $57.
00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. William Blair reissued a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th.
Bank of America upped their price target on shares of Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a report on Monday, March 3rd.
Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Finally, Piper Sandler cut their price objective on Tempus AI from $70.00 to $55.
00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.
com, the company has an average rating of “Moderate Buy” and an average target price of $61.18. Tempus AI Trading Down 7.
8 % Shares of Tempus AI stock opened at $42.58 on Friday. Tempus AI, Inc.
has a fifty-two week low of $22.89 and a fifty-two week high of $91.45.
The business’s fifty day moving average is $58.27 and its two-hundred day moving average is $51.45.
The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.
55. Insider Buying and Selling In related news, Director Jennifer A. Doudna sold 1,320 shares of the company’s stock in a transaction that occurred on Friday, February 14th.
The shares were sold at an average price of $90.00, for a total transaction of $118,800.00.
Following the completion of the transaction, the director now owns 36,011 shares of the company’s stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock.
The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink . Also, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction on Friday, January 31st.
The shares were sold at an average price of $60.00, for a total transaction of $826,200.00.
Following the completion of the transaction, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their position.
The disclosure for this sale can be found here . Over the last ninety days, insiders have sold 5,601,969 shares of company stock worth $317,330,782. About Tempus AI ( Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare.
The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Further Reading Five stocks we like better than Tempus AI Overbought Stocks Explained: Should You Trade Them? Conagra Stock Could Thrive as Tariffs Hit Other Sectors Why Understanding Call Option Volume is Essential to Successful Options Trading Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds High Flyers: 3 Natural Gas Stocks for March 2022 Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy? Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc.
( NASDAQ:TEM – Free Report ). Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter .
.
